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Purpose. To study the safety of intravitreal injections of poly-N-isopropylacrylamide (pNIPAM) tissue adhesive in rabbit
eyes. Methods. Twelve study rabbits received an intravitreal injection of 0.1mL 50% pNIPAM in the right eye. Follow-up
examinations included color fundus photography, fundus fluorescein angiography (FA), optical coherence tomography (OCT), and
electroretinography (ERG). Subsequent to the last follow-up assessment, the rabbits were sacrificed and histopathological study on
the scleral incision sites was performed. Results. All study animals developed mild to moderate levels of inflammatory reaction
in the conjunctiva, anterior chamber, and the anterior vitreous during the first month of follow-up. After this period, the level of
the inflammatory reaction progressively decreased and completely disappeared after the third month of follow-up. The lens and
cornea remained clear during the entire follow-up period. OCT and FA did not show areas of retinal damage or neovascularization.
Histological and ERG studies of eyes injected with pNIPAM demonstrated absence of retinal toxicity. Conclusion. Intravitreal
injections of pNIPAM were nontoxic in this animal study, and pNIPAM may be safe to be used as a bioadhesive in certain retinal
diseases.
1. Introduction
Potential applications for tissue adhesive in ophthalmol-
ogy surgery have generated growing interest. Adhesives are
already being successfully used in the treatment of various
anterior segments conditions [1–10]. Experimental models
of rhegmatogenous retinal detachment and repair during
vitreous surgery have been reported using transvitreal tissue
adhesives such as cyanoacrylate, fibrin glue, and transform-
ing growth factor-beta for retinopexy [11–15]. However, many
of the tested adhesives elicited severe inflammation of the eye.
Some proved to be toxic to the retina; others did not have
sufficient adhesive strength. As most polymeric adhesives
form very rapidly via a highly exothermic reaction, the heat
and the chemical impurities discharged during the reaction
can cause toxic damage and inflammatory response [16]. A
safe and effective adhesive could potentially be used to man-
age retinal tears and treat macular holes and selected cases
of retinal detachment (RD). However, an adhesive meet-
ing these criteria for retinal tissue is not yet available for use.
Poly-N-Isopropylacrylamide (pNIPAM) is the most
broadly studied thermoresponsive polymer for therapeutic
targets. pNIPAM has reversible phase transition upon heat
and inverse solubility. Below its lower critical solution
temperature (LCST), that is, 32∘C, it is hydrophilic and water
soluble. However, above 32∘C, it is hydrophobic and turns
into a viscous gel which adheres to tissue [17]. pNIPAM has
been already used for therapeutic purposes, for example, in
drug targeting for solid tumors [18, 19], in drug delivery as a
thermosensitive coating [20, 21], and in tissue culture as a cell
detachment/attachment factor [22, 23].This polymer has also
been used in eye drop preparations and in neurosurgery as
an embolic substance. In such cases, no in vitro cytotoxicity
or acute toxicity in mice was noted [24–26].
The purpose of this study is to evaluate the ocular safety of
pNIPAM, using clinical, electrophysiological, and histologic
Hindawi Publishing Corporation
Journal of Ophthalmology
Volume 2016, Article ID 5356371, 6 pages
http://dx.doi.org/10.1155/2016/5356371
2 Journal of Ophthalmology
assessments, after intravitreal injections of excess quantities
of pNIPAM adhesive preparations in the rabbit eye.
2. Methods
pNIPAM was synthesized through bulk polymerization of
1.0 g of N-isopropylacrylamide (NIPAM) with 0.0145 g of
2, 2-azobisisobutyronitrile (AIBN) in 14mL of ethanol. The
mixture was heated with an oil bath set at 65∘C for 16
hours under constant stirring. After removal of ethanol under
vacuum, the polymer was dissolved in a minimum amount
of tetrahydrofuran and recrystalized by the addition of ether.
The solid precipitates were collected and air dried. The solid
pNIPAM was then dissolved in phosphate-buffered saline at
a 50% concentration.
Studies were in compliance with the ARVO statement
on the Use of Animals in Ophthalmic and Visual Research.
After Institutional Animal Care and Use Committee and
Institutional Review Board approval from the University
of Southern California, twelve New Zealand pigmented
rabbits weighing between 2 and 4 kg underwent intravit-
real injections of pNIPAM. Preoperative pain control was
achieved. The rabbits were anesthetized and the procedure
was performed under sterile conditions. A 28-gauge needle
was obliquely and transconjunctivaly inserted through the
superior sclera, 1.5mm behind the limbus. The needle was
inserted into the vitreous under direct vitreous cavity view
using a 65-diopter fundus lens. Once in the vitreous cavity,
the syringe was directed so that the needle tip came to lie
just anterior to the posterior retina. The bevel of the needle
was directed toward the inferior retina, and 0.1mL of the 50%
tissue adhesive was injected. No leakage occurred at any time
during the injection procedure.
At regular intervals, the rabbits underwent routine
evaluations, including slit-lamp examinations, intraocular
pressure measurement, indirect ophthalmoscopy, external
and fundus color photography, fundus fluorescein angiogra-
phy (FA), optical coherence tomography (OCT), and elec-
troretinography (ERG). Slit-lamp examinations and indirect
ophthalmoscopy were performed preoperatively, immedi-
ately after injection and on days 1, 2, 4, 7, and 14, and monthly
thereafter for 6 months. Intraocular pressure was measured
with a tonometer at each examination. FA and external and
fundus photography were performed before operation, on
day 14, and then on monthly basis for 6 months. ERG was
recorded before operation, on day 14, and on monthly basis
thereafter, using an Espion Visual Electrophysiology unit
(Diagnosys LLC, Lowell, MA, USA) [27, 28].
After the last follow-up examination, the rabbits were
sacrificed using an intracardiac injection of pentobarbital.
Then, the eyes were enucleated, placed in Davidson fixative
medium, and embedded in paraffin before sectioning. Histo-
logical study was performed in all study eyes. Tissue slices of
10 𝜇m from the frozen sections were cut until the sclerotomy
location was reached and were stained with hematoxylin and
eosin. Digital photographs from the histological slides were
taken and studied using the NIH Image software (version
1.62, National Institutes of Health, Bethesda, MD).
3. Results
Following liquid pNIPAM intravitreal injection, glue poly-
merization occurred rapidly in the posterior vitreous; a
filament of the glue also remained at the injection site as the
needle was removed from the rabbit eye. Mechanical damage
to the sclera and conjunctiva aside from at the injection sites
themselves was not observed.
All the animals showed mild to moderate chemosis and
conjunctival swelling during the first month of follow-up.
The amount of chemosis and conjunctival swelling gradually
decreased and, at the third month of follow-up, minimal
anterior segment inflammation was visible. The same level
of inflammatory reaction was also observed in the anterior
chamber and in the anterior vitreous during the first 7 follow-
up days. After this period, the amount of the inflammatory
reaction progressively decreased and completely disappeared
after the third month of the follow-up period. Lens and
cornea remained clear during the entire follow-up period.
Intraocular pressure remained normal, ranging from 12 to
18mmHg in the study eyes. Infection or fundus lesions, such
as retinal thinning, retinal whitening, or chorioretinal adhe-
sion around the optic disc and medullary wings, were not
detected in any of the eyes during the follow-up period. OCT
did not reveal retinal abnormalities such as hyperreflectivity
of the outer retina or any chorioretinal thinning. Areas of
retinal hypo/hyperfluorescence or neovascularization were
not observed on FA in any of the rabbits (Figure 1). During
the study follow-up, the mean b-wave amplitude ratios
of electroretinogram recordings (eyes with pNIPAM injec-
tion/fellow eyes) remained close to 1 (Figure 2). Comparisons
in pair of the preoperative b-wave ratios versus the ratios at
each time exam revealed no significant differences (𝑃 < 0.5)
when calculated with Student’s 𝑡-test.
The enucleated eyes were halved and the interior wounds
grossly observed. All inside wounds were sealed and no
vitreous incarceration or hemorrhage was detected at the
sclerotomy locations. Light microscopy demonstrated an
unremarkable anterior segment and the absence of cataract
or intraocular inflammation in the sectioned eyes.Therewere
no signs of retinal toxicity, such as inner or outer retinal
atrophy, and the longitudinal sections of the optic nerve were
unremarkable (Figure 3).
4. Discussion
A thermosensitive reversible adhesive could have several
applications in the ophthalmology field, such as in intraocular
drug delivery, posterior segment surgery, and implantation
of biomimetic microelectronic devices. Preceding studies
have shown that pNIPAM has a LCST of 32∘C [29, 30].
This means that this thermosensitive hydrogel possesses
decreased solubility in water as the temperature is raised due
to a phase transformation at its LCST [29, 30]. Therefore,
pNIPAM can be changed from a cellular detachment state
to a cellular attachment state by changing the temperature
of the tissue surface [29]. Due to its sharp property switch
and the capability to transform the polymer into a solid
state, pNIPAM could be categorized as a specialized chemical
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Figure 1: Color fundus photographs, fundus fluorescein angiography, and optical coherence tomography (OCT) from the baseline (A, B,
and C), 3 months (D, E, and F), and 6 months follow-up (G, H, and I). There were no retinal or optic disc abnormalities in the study rabbits
during the follow-up period.
adhesive that may allow for applications that were formerly
too complex or difficult to consider.
In our study, pNIPAM was injected intravitreally. The
volume of pNIPAM injected was relatively large, especially
when compared with the minute amounts delivered to the
chorioretinal junction in both experimental models and sur-
gical series of cyanoacrylate retinopexy for rhegmatogenous
RD [31–33]. The excess quantity of pNIPAM did not cause
any discernible distant ocular effects or localized retinal
changes in the vicinity of the polymerized glue. There was
no noticeable mechanical or chemical adverse reaction on
the retina. Inflammatory reaction observed in the anterior
chamber and the vitreous in the first days following the
surgical procedure is a normal response observed in eyes
that have undergone intravitreal injections. These effects,
however, disappeared during the follow-up period.
The ideal adhesive for intraocular use should be safe,
effective, and easy to use. In other words, it should be
noninflammatory and nontoxic, possess a short curing time,
have sufficient duration and strength of adhesion, and be
easily deliverable.There is yet no standardizedmethod to test
the in vitro adhesive power of a material with the retina but a
safe and effective adhesive could potentially be particularly
useful in the posterior segment. In certain complicated
cases of retinal detachment, an adhesive may obviate the
need for internal tamponade, retinal laser photocoagulation,
and face-down postoperative positioning. A retinal adhesive
that achieves and maintains immediate closure of the hole,
independent of body positioning, could ease the position and
travel restrictions placed on these patients. Another poten-
tial application for intraocular adhesives would be in the
attachment of retinal prostheses to the retina. Several groups
around the world [34–37] are developing a retinal prosthetic
device that will allow useful vision to be restored to patients
with retinal degenerative diseases such as retinitis pigmentosa
or age-related macular degeneration. Different methods have
been proposed to attach this device to the retina, such as
placing the device under the retina (a procedure that would
not require array fixation) and the use of retinal tacks and
different biocompatible glues [35, 36, 38].
Although N-isopropylacrylamide monomer is toxic
to neural tissue, following polymerization, the pNIPAM
4 Journal of Ophthalmology
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Figure 2: Mean b-wave amplitude response curves and implicit time responses at 6 months. (a and b) Eyes which underwent intravitreal
injection of 0.1mL of pNIPAM demonstrate a slight depression of scotopic and photopic responses when compared to respective control
fellow eyes (c and d). Comparisons of the preoperative b-wave ratios versus the ratios at each time exam revealed no significant differences
(𝑃 < 0.5) when calculated with the Student 𝑡-test.
Figure 3: (A) Light microscopy of the retina 6 months after intravitreal injection of pNIPAM. The ganglion cell layer is facing upwards.
Signs of retinal toxicity such as inner or outer retinal atrophy were not detected. (B) Light microscopy of the anterior chamber 6 months
after intravitreal injection of pNIPAM.The iris tissue is facing upwards. The iris and the anterior chamber angle showed no abnormalities or
damage.
molecule is no longer toxic to neural tissue and is commonly
used in cell cultures and tissue cultures for its reversible cell
adhesion properties [24, 29, 39]. pNIPAM has also been used
in retinal pigment epithelium (RPE) cell cultures to provide
RPE sheets for transplantation; these RPE cells preserved
their morphology with no signs of toxicity [39]. Interestingly,
pNIPAM has also been used to stop bleeding in experimental
liver injuries and no toxicity has been reported [40]. To our
knowledge there is no previous report on the in vivo effects
of pNIPAM inside the eye.
In conclusion, intravitreal injections of pNIPAM in close
proximity to retina showed limited intraocular inflammation
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without localized or diffuse retinal toxicity in the rabbit eye.
pNIPAM proved to be safe for intravitreal injection in rabbits
and if comparable safety is shown when applied to the retinal
surface, it has the potential to be used for the management
of retinal diseases such as rhegmatogenous RD, optic disc pit,
and macular hole.
Additional Points
Summary Statement. Intravitreal injections of poly-N-
isopropylacrylamide in rabbits appear to be safe. Future
studies are needed to evaluate the potential of pNIPAM as a
bioadhesive in the treatment of retinal diseases.
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